Development and Concordance of Binding and Neutralizing Assays to Determine SARS-CoV-2 Antibody Activity in Human Milk.

Saved in:
Bibliographic Details
Title: Development and Concordance of Binding and Neutralizing Assays to Determine SARS-CoV-2 Antibody Activity in Human Milk.
Authors: Shriver MC; Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, Maryland., Milletich PL; Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, Maryland., Moreno A; Center for Childhood Infections and Vaccines, Children's Healthcare of Atlanta, Division of Infectious Diseases, Department of Pediatrics, Emory Vaccine Center, Emory University, Atlanta, Georgia.; Emory National Primate Research Center, Atlanta, Georgia.; Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia., Larsen SE; Seattle Children's Research Institute, Center for Global Infectious Disease Research, Seattle, Washington., Posavad CM; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington., Berube BJ; Seattle Children's Research Institute, Center for Global Infectious Disease Research, Seattle, Washington., Wali B; Center for Childhood Infections and Vaccines, Children's Healthcare of Atlanta, Division of Infectious Diseases, Department of Pediatrics, Emory Vaccine Center, Emory University, Atlanta, Georgia.; Emory National Primate Research Center, Atlanta, Georgia., Ellis M; Center for Childhood Infections and Vaccines, Children's Healthcare of Atlanta, Division of Infectious Diseases, Department of Pediatrics, Emory Vaccine Center, Emory University, Atlanta, Georgia.; Emory National Primate Research Center, Atlanta, Georgia., Manning K; Center for Childhood Infections and Vaccines, Children's Healthcare of Atlanta, Division of Infectious Diseases, Department of Pediatrics, Emory Vaccine Center, Emory University, Atlanta, Georgia.; Emory National Primate Research Center, Atlanta, Georgia., Moore KM; Center for Childhood Infections and Vaccines, Children's Healthcare of Atlanta, Division of Infectious Diseases, Department of Pediatrics, Emory Vaccine Center, Emory University, Atlanta, Georgia.; Emory National Primate Research Center, Atlanta, Georgia., Zhu Z; Seattle Children's Research Institute, Center for Global Infectious Disease Research, Seattle, Washington., Grewal N; Seattle Children's Research Institute, Center for Global Infectious Disease Research, Seattle, Washington., Cadena IA; Seattle Children's Research Institute, Center for Global Infectious Disease Research, Seattle, Washington., Cardemil CV; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland., Munoz FM; Departments of Pediatrics and Molecular Virology & Microbiology, Baylor College of Medicine, and Texas Children's Hospital, Houston, Texas., Neuzil KM; Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, Maryland., Coler RN; Seattle Children's Research Institute, Center for Global Infectious Disease Research, Seattle, Washington.; University of Washington School of Medicine, Department of Pediatrics, Seattle, Washington.; University of Washington Department of Global Health, Seattle, Washington., Suthar MS; Center for Childhood Infections and Vaccines, Children's Healthcare of Atlanta, Division of Infectious Diseases, Department of Pediatrics, Emory Vaccine Center, Emory University, Atlanta, Georgia.; Emory National Primate Research Center, Atlanta, Georgia.; Division of Infectious Diseases, Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia., Pasetti MF; Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, Maryland.
Corporate Authors: MOMI-Vax Study Group
Source: Pathogens & immunity [Pathog Immun] 2025 May 22; Vol. 10 (2), pp. 97-121. Date of Electronic Publication: 2025 May 22 (Print Publication: 2025).
Publication Type: Journal Article
Journal Info: Publisher: Case Western Reserve University Country of Publication: United States NLM ID: 101683909 Publication Model: eCollection Cited Medium: Internet ISSN: 2469-2964 (Electronic) Linking ISSN: 24692964 NLM ISO Abbreviation: Pathog Immun Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2469-2964
DOI:10.20411/pai.v10i2.799